Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Abdominal Radiology
Erschienen in: Abdominal Radiology 12/2016

30.06.2016

Multimodality imaging of locally recurrent and metastatic cervical cancer: emphasis on histology, prognosis, and management

verfasst von: Kye Jin Park, Marta Braschi-Amirfarzan, Pamela J. DiPiro, Angela A. Giardino, Jyothi P. Jagannathan, Stephanie A. Howard, Atul B. Shinagare, Katherine M. Krajewski

Erschienen in: Abdominal Radiology | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

The management of recurrent and metastatic cervical cancer is evolving in concert with the available advanced imaging techniques and molecular targeted therapy. The purpose of this review is to provide an overview of imaging and treatment of cervical cancer patients with locoregional recurrence and metastatic disease, with emphasis on characteristic patterns of spread based on histology (squamous cell carcinoma and other subtypes), prognostic factors, diagnosis, and treatment response assessment, as well as updated therapeutic options.
Literatur
1.
Ferlay J, Soerjomataram I, Dikshit R, et al. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed
2.
3.
Chan PG, Sung HY, Sawaya GF (2003) Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol 102(4):765–773PubMed
4.
Friedlander M, Grogan M (2002) Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist 7:342–347PubMed
5.
Koh WJ, Greer BE, Abu-Rustum NR, et al. (2015) Cervical Cancer, Version 2.2015. J Natl Compr Canc Netw 13:395–404; quiz 404
6.
Colombo N, Carinelli S, Colombo A, et al. (2012) Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii27–vii32PubMed
7.
Salani R, Backes FJ, Fung MF, et al. (2011) Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol 204:466–478CrossRefPubMed
8.
Quinn MA, Benedet JL, Odicino F, et al. (2006) Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95(Suppl 1):S43–S103CrossRefPubMed
9.
Drescher CW, Hopkins MP, Roberts JA (1989) Comparison of the pattern of metastatic spread of squamous cell cancer and adenocarcinoma of the uterine cervix. Gynecol Oncol 33:340–343CrossRefPubMed
10.
11.
Kusmirek J, Robbins J, Allen H, et al. (2015) PET/CT and MRI in the imaging assessment of cervical cancer. Abdom Imaging 40(7):2486–2511CrossRefPubMed
12.
Kitajima K, Suenaga Y, Ueno Y, et al. (2014) Fusion of PET and MRI for staging of uterine cervical cancer: comparison with contrast-enhanced (18)F-FDG PET/CT and pelvic MRI. Clin Imaging 38:464–469CrossRefPubMed
13.
Chen J, Macdonald OK, Gaffney DK (2008) Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix. Obstet Gynecol 111:1394–1402CrossRefPubMed
14.
Vinh-Hung V, Bourgain C, Vlastos G, et al. (2007) Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer 7:164CrossRefPubMedPubMedCentral
15.
Look KY, Brunetto VL, Clarke-Pearson DL, et al. (1996) An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 63:304–311CrossRefPubMed
16.
Eifel PJ, Burke TW, Morris M, Smith TL (1995) Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 59:38–44CrossRefPubMed
17.
Galic V, Herzog TJ, Lewin SN, et al. (2012) Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol 125:287–291CrossRefPubMed
18.
Hopkins MP, Morley GW (1991) A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 77:912–917PubMed
19.
Lee JY, Kim YT, Kim S, et al. (2015) Prognosis of cervical cancer in the era of concurrent chemoradiation from National Database in Korea: a comparison between squamous cell carcinoma and adenocarcinoma. PLoS One 10:e0144887CrossRefPubMedPubMedCentral
20.
Intaraphet S, Kasatpibal N, Sogaard M, et al. (2014) Histological type-specific prognostic factors of cervical small cell neuroendocrine carcinoma, adenocarcinoma, and squamous cell carcinoma. Onco Targets Ther 7:1205–1214PubMedPubMedCentral
21.
Intaraphet S, Kasatpibal N, Søgaard M, et al. (2014) Histological type-specific prognostic factors of cervical small cell neuroendocrine carcinoma, adenocarcinoma, and squamous cell carcinoma. Onco Targets Ther. 7:1205–1214PubMedPubMedCentral
22.
Lee SW, Lim KT, Bae DS, et al. (2015) A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix. Gynecol Obstet Invest. 79(3):172–178CrossRefPubMed
23.
Je HU, Han S, Kim YS, et al. (2014) A nomogram predicting the risks of distant metastasis following postoperative radiotherapy for uterine cervical carcinoma: a Korean radiation oncology group study (KROG 12-08). Radiother Oncol 111:437–441CrossRefPubMed
24.
Kang S, Nam BH, Park JY, et al. (2012) Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: a Korean gynecologic oncology group study. J Clin Oncol 30:2369–2374CrossRefPubMed
25.
Kim MK, Jo H, Kong HJ, et al. (2010) Postoperative nomogram predicting risk of recurrence after radical hysterectomy for early-stage cervical cancer. Int J Gynecol Cancer 20:1581–1586PubMed
26.
Polterauer S, Grimm C, Hofstetter G, et al. (2012) Nomogram prediction for overall survival of patients diagnosed with cervical cancer. Br J Cancer 107:918–924CrossRefPubMedPubMedCentral
27.
Seo Y, Yoo SY, Kim MS, et al. (2011) Nomogram prediction of overall survival after curative irradiation for uterine cervical cancer. Int J Radiat Oncol Biol Phys 79:782–787CrossRefPubMed
28.
Tseng JY, Yen MS, Twu NF, et al. (2010) Prognostic nomogram for overall survival in stage IIB-IVA cervical cancer patients treated with concurrent chemoradiotherapy. Am J Obstet Gynecol 202:174.e171–174.e177CrossRef
29.
Bodurka-Bevers D, Morris M, Eifel PJ, et al. (2000) Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol 78:187–193CrossRefPubMed
30.
Samlal RA, Van Der Velden J, Van Eerden T, et al. (1998) Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer 8:78–84CrossRefPubMed
31.
Zola P, Fuso L, Mazzola S, et al. (2007) Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gynecol Oncol 107:S150–S154CrossRefPubMed
32.
Farley JH, Hickey KW, Carlson JW, et al. (2003) Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer 97:2196–2202CrossRefPubMed
33.
Crowder S, Tuller E (2007) Small cell carcinoma of the female genital tract. Semin Oncol 34:57–63CrossRefPubMed
34.
Silva-Melendez PE, Escobar PF, Hector S, et al. (2015) Small cell carcinoma of the uterine cervix: a case report and literature review. Bol Asoc Med P R 107:55–57PubMed
35.
Cohen JG, Kapp DS, Shin JY, et al. (2010) Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am J Obstet Gynecol 203(347):e341–e346
36.
Burke TW, Hoskins WJ, Heller PB, et al. (1987) Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma. Obstet Gynecol 69:382–385PubMed
37.
Rintala MA, Rantanen VT, Salmi TA, et al. (1997) PAP smear after radiation therapy for cervical carcinoma. Anticancer Res 17:3747–3750PubMed
38.
Clavero JM, Deschamps C, Cassivi SD, et al. (2006) Gynecologic cancers: factors affecting survival after pulmonary metastasectomy. Ann Thorac Surg 81:2004–2007CrossRefPubMed
39.
Hong JH, Tsai CS, Lai CH, et al. (2004) Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys 60:249–257CrossRefPubMed
40.
Nagellvan JR, Rayburn W, Donaldson ES (1979) Therapeutic implications of patterns of recurrence in cancer of the uterine cervix. Cancer 44:2354–2361CrossRef
41.
Sardain H, Lavoue V, Redpath M, et al. (2015) Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review. Eur J Surg Oncol 41:975–985CrossRefPubMed
42.
Deutsch M, Parsons JA (1974) Radiotherapy for carcinoma of the cervix recurrent after surgery. Cancer 34:2051–2055CrossRefPubMed
43.
Heron CW, Husband JE, Williams MP, et al. (1988) The value of CT in the diagnosis of recurrent carcinoma of the cervix. Clin Radiol 39:496–501CrossRefPubMed
44.
Walsh JW, Amendola MA, Hall DJ, et al. (1981) Recurrent carcinoma of the cervix: CT diagnosis. AJR Am J Roentgenol 136:117–122CrossRefPubMed
45.
Hricak H, Swift PS, Campos Z, et al. (1993) Irradiation of the cervix uteri: value of unenhanced and contrast-enhanced MR imaging. Radiology 189:381–388CrossRefPubMed
46.
Brown JJ, Gutierrez ED, Lee JK (1992) MR appearance of the normal and abnormal vagina after hysterectomy. AJR Am J Roentgenol 158:95–99CrossRefPubMed
47.
Ebner F, Kressel HY, Mintz MC, et al. (1988) Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5 T. Radiology 166:333–340CrossRefPubMed
48.
Weber TM, Sostman HD, Spritzer CE, et al. (1995) Cervical carcinoma: determination of recurrent tumor extent versus radiation changes with MR imaging. Radiology 194:135–139CrossRefPubMed
49.
Sala E, Rockall A, Rangarajan D, Kubik-Huch RA (2010) The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis. Eur J Radiol 76:367–385CrossRefPubMed
50.
Hawighorst H, Knapstein PG, Schaeffer U, et al. (1996) Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions. AJR Am J Roentgenol 166:401–408CrossRefPubMed
51.
Kinkel K, Ariche M, Tardivon AA, et al. (1997) Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. Radiology 204:55–63CrossRefPubMed
52.
Donati OF, Lakhman Y, Sala E, et al. (2013) Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration. Eur Radiol 23:2906–2915CrossRefPubMed
53.
Lucas R, Lopes Dias J, Cunha TM (2015) Added value of diffusion-weighted MRI in detection of cervical cancer recurrence: comparison with morphologic and dynamic contrast-enhanced MRI sequences. Diagn Interv Radiol 21:368–375CrossRefPubMedPubMedCentral
54.
Lee M, Lee Y, Hwang KH, et al. (2011) Usefulness of F-18 FDG PET/CT in assessment of recurrence of cervical cancer after treatment. Nucl Med Mol Imaging 45:111–116CrossRefPubMedPubMedCentral
55.
Mittra E, El-Maghraby T, Rodriguez CA, et al. (2009) Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma. Eur J Nucl Med Mol Imaging 36:1952–1959CrossRefPubMedPubMedCentral
56.
van der Veldt AA, Buist MR, van Baal MW, et al. (2008) Clarifying the diagnosis of clinically suspected recurrence of cervical cancer: impact of 18F-FDG PET. J Nucl Med 49:1936–1943CrossRefPubMed
57.
Wong TZ, Jones EL, Coleman RE (2004) Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-d-glucose for evaluating local and distant disease in patients with cervical cancer. Mol Imaging Biol 6:55–62CrossRefPubMed
58.
Caceres A, Mourton SM, Bochner BH, et al. (2008) Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery. Int J Gynecol Cancer 18:1139–1144CrossRefPubMed
59.
Chen MF, Tseng CJ, Tseng CC, et al. (2007) Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67:1438–1444CrossRefPubMed
60.
Shin MS, Shingleton HM, Partridge EE, et al. (1995) Squamous cell carcinoma of the uterine cervix. Invest Radiol 30:724–729CrossRefPubMed
61.
Ghosh S, Rao PB (2015) Osseous metastases in gynaecological epithelial malignancies: a retrospective institutional study and review of literature. J Clin Diagn Res 9:XC10–XC13PubMedPubMedCentral
62.
McMahon CJ, Rofsky NM, Pedrosa I (2010) Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging. Radiology 254(1):31–46CrossRefPubMed
63.
Bipat S, Glas AS, van der Velden J (2003) Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 91:59–66CrossRefPubMed
64.
Lin G, Ho KC, Wang JJ, et al. (2008) Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging 28:128–135CrossRefPubMed
65.
Rockall AG, Sohaib SA, Harisinghani MG, et al. (2005) Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23:2813–2821CrossRefPubMed
66.
Sironi S, Buda A, Picchio M, et al. (2006) Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 238:272–279CrossRefPubMed
67.
Choi HJ, Roh JW, Seo SS, et al. (2006) Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer 106:914–922CrossRefPubMed
68.
Patel CN, Nazir SA, Khan Z, et al. (2011) 18F-FDG PET/CT of cervical carcinoma. AJR Am J Roentgenol 196:1225–1233CrossRefPubMed
69.
Yamamoto K, Yoshikawa H, Shiromizu K, et al. (2004) Pulmonary metastasectomy for uterine cervical cancer: a multivariate analysis. Ann Thorac Surg 77:1179–1182CrossRefPubMed
70.
Moore DH, Blessing JA, McQuellon RP, et al. (2004) Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 22:3113–3119CrossRefPubMed
71.
Mackay HJ, Tinker A, Winquist E, et al. (2010) A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184. Gynecol Oncol 116:163–167CrossRefPubMed
72.
Monk BJ, Mas Lopez L, Zarba JJ, et al. (2010) Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer. J Clin Oncol 28:3562–3569CrossRefPubMed
73.
Pfaendler KS, Tewari KS (2015) Changing paradigms in the systemic treatment of advanced cervical cancer. Am J Obstet Gynecol 214(1):22–30CrossRefPubMed
74.
Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH (2013) Liver metastases in the era of molecular targeted therapy: new faces of treatment response. AJR Am J Roentgenol 201:W15–W28CrossRefPubMed
75.
Howard SA, Krajewski KM, Thornton E, et al. (2012) Decade of molecular targeted therapy: abdominal manifestations of drug toxicities–what radiologists should know. AJR Am J Roentgenol 199:58–64CrossRefPubMed
76.
Shinagare AB, Howard SA, Krajewski KM, et al. (2012) Pneumatosis intestinalis and bowel perforation associated with molecular targeted therapy: an emerging problem and the role of radiologists in its management. AJR Am J Roentgenol 199:1259–1265CrossRefPubMed
77.
Tirumani SH, Fairchild A, Krajewski KM, et al. (2015) Anti-VEGF molecular targeted therapies in common solid malignancies: comprehensive update for radiologists. Radiographics 35:455–474CrossRefPubMed
78.
Biewenga P, Mutsaerts MA, Stalpers LJ, et al. (2010) Can we predict vesicovaginal or rectovaginal fistula formation in patients with stage IVA cervical cancer? Int J Gynecol Cancer 20:471–475CrossRefPubMed
79.
Moore KN, Gold MA, McMeekin DS, Zorn KK (2007) Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma. Gynecol Oncol 106:498–501CrossRefPubMed
80.
Hareyama H, Hada K, Goto K, et al. (2015) Prevalence, classification, and risk factors for postoperative lower extremity lymphedema in women with gynecologic malignancies: a retrospective study. Int J Gynecol Cancer 25:751–757CrossRefPubMed
81.
Moreno A, Clemente J, Crespo C, et al. (1999) Pelvic insufficiency fractures in patients with pelvic irradiation. Int J Radiat Oncol Biol Phys 44:61–66CrossRefPubMed
82.
Uezono H, Tsujino K, Moriki K, et al. (2013) Pelvic insufficiency fracture after definitive radiotherapy for uterine cervical cancer: retrospective analysis of risk factors. J Radiat Res 54:1102–1109CrossRefPubMedPubMedCentral
83.
Blomlie V, Rofstad EK, Talle K, et al. (1996) Incidence of radiation-induced insufficiency fractures of the female pelvis: evaluation with MR imaging. AJR Am J Roentgenol 167:1205–1210CrossRefPubMed
84.
Kwon JW, Huh SJ, Yoon YC, et al. (2008) Pelvic bone complications after radiation therapy of uterine cervical cancer: evaluation with MRI. AJR Am J Roentgenol 191:987–994CrossRefPubMed
85.
Shih KK, Folkert MR, Kollmeier MA, et al. (2013) Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postoperative pelvic radiation. Gynecol Oncol 128:540–543CrossRefPubMed
86.
Boice JD Jr, Day NE, Andersen A, et al. (1985) Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 74:955–975PubMed
87.
88.
Kim JH, Chu FC, Woodard HQ, et al. (1978) Radiation-induced soft-tissue and bone sarcoma. Radiology 129:501–508CrossRefPubMed
89.
Rosen MA, Schnall MD (2007) Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma. Clin Cancer Res 13:770s–776sCrossRefPubMed
90.
Park DH, Kim KH, Park SY, et al. (2000) Diagnosis of recurrent uterine cervical cancer: computed tomography versus positron emission tomography. Korean J Radiol 1:51–55CrossRefPubMedPubMedCentral
Metadaten
Titel
Multimodality imaging of locally recurrent and metastatic cervical cancer: emphasis on histology, prognosis, and management
verfasst von
Kye Jin Park
Marta Braschi-Amirfarzan
Pamela J. DiPiro
Angela A. Giardino
Jyothi P. Jagannathan
Stephanie A. Howard
Atul B. Shinagare
Katherine M. Krajewski
Publikationsdatum
30.06.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 12/2016
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0825-5

Weitere Artikel der Ausgabe 12/2016

Abdominal Radiology 12/2016 Zur Ausgabe

Pictorial Essay

Deep pelvic endometriosis: a radiologist’s guide to key imaging features with clinical and histopathologic review

OriginalPaper

Clear cell carcinoma of the ovary: comparison of MR findings of histological subtypes

OriginalPaper

Premedication of pregnant patients with history of iodinated contrast allergy

OriginalPaper

Sonographic evaluation of deep endometriosis: protocol for a US radiology practice

Pictorial Essay

Magnetic resonance imaging of fetal pelvic cysts

Invited article

MR imaging of atypical fibroids

Neu im Fachgebiet Radiologie

23.04.2024 | Pankreaskarzinom | Nachrichten

S3-Leitlinie zu Pankreaskrebs aktualisiert

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

13.04.2024 | Klinik aktuell | Kongressbericht | Nachrichten

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

08.04.2024 | Andrologie | Nachrichten

Wie toxische Männlichkeit der Gesundheit von Männern schadet
weitere anzeigen

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen